SORT BY Relevancy
Join us for our second interview on Myeloma Crowd Radio highlighting the new Myeloma Crowd Research Initiative on high-risk myeloma. As part of this series, Dr. Guenther Koehne, MD, PhD of the Memorial Sloan Kettering Cancer Center will share his use of a T cell vaccine with an allogeneic transplant to provide outstanding results, even in plasma leukemia patients. His research pulls out T cells, marks them with a tag to target the WT1 protein, and are given back. He will describe how this works, the impact he has seen so far, the stage of his clinical trial and the work left to do to make this an available therapy for high-risk myeloma patients.
Dr. Guenther Kohene, MD, PhD is Medical Director of the Cell Therapy Laboratory in the Bone Marrow Transplantation Laboratory at Sloan Kettering. He is also Assistant Member and Assistant Attending Physician in the Allogeneic Bone Marrow Transplantation Service. He is Assistant Professor of the Joan and Sanford Weill Medical College of Cornell University. He leads research at the BMT Department/Immunology Program to develop adoptive immunotherapeutic strategies for post-transplant blood disorders. He has particular expertise in the creation and monitoring of antigen-specific T cell responses in these patients. He is the Principal Investigator in active clinical trials using adoptive cell therapy following allogeneic stem cell transplants for multiple myeloma and plasma cell leukemia patients. He obtained his medical degree at the University of Hamburg, Germany and has been at Memorial Sloan Kettering Cancer Center permanently since 2005.
Special thanks to our Myeloma Crowd Radio Episode sponsor, Takeda Oncology.
ALS Crowd Radio: Dr. Jonathan Katz on the "Right to Try"
Myeloma is not a single disease. Two types of high-risk myeloma have swapped chromosomes (14;16) and (14;20) have notoriously short survival times with conventional treatments and are found to be resistant to bortezomib, one of the standard myeloma therapies. Dr. Frank Zhan, MD, PhD of the University of Iowa searched a genetic database to identify 100 genes uniquely deregulated for these two types of myeloma. Based on database matching to find compounds that induce or reverse desired gene changes, he found 5 targets to affect the c-MAF and MAFB genes that are disregulated by these translocations. They found that only Alsterpaullon (ALP) significantly inhibits MM cell growth with “spike” expression of either c-MAF or MAFB. ALP is a cyclindependent kinase (CDK) inhibitor and blocks cell-cycle progression. However, the reasons for its antiproliferative effects is unknown. The research will test whether ALP is able to disable c-MAF/MAFB signaling events, thus rendering MM responsive to chemotherapeutics.
Join us for this 6th show of the Myeloma Crowd Research Initiative with Dr. Frank Zhan, MD, PhD and Dr. Guido Tricot, MD, PhD to discuss a potential solution for these patients in a truly personalized medicine fashion.
Dr. Ivan Borrello, MD of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, joins us as part of the top 10 projects selected by the Myeloma Crowd Research Initiative. He shares his pioneering work using patients' own immune cells to fight their cancer. His group leads the research for this type of immunotherapy, called adaptive T-cell therapy with MILS (marrow infiltrating lymphocytes). This vaccine is a version for multiple myeloma of those already successful to treat pancreas, prostate and breast cancers. Learn more about this important work in his upcoming study in multiple myeloma.
Join us for this first interview on Myeloma Crowd Radio highlighting new Myeloma Crowd Research Initiative on high-risk myeloma. For the first time, patients and doctors are joining together to find and fund research for patient group that is desperate for new options. The MCRI initiative reached out the the worldwide community and asked them to submit their research proposals for high-risk patients. We received 36 high quality proposals from all over the world. The MCRI Scientific Advisory Board then scored the proposals, selecting 10 for further review. These ten will be included in the Myeloma Crowd Radio/MCRI series on high-risk.
As part of this series, Dr. Craig Hofmeister, MD from Ohio State University will share his research being done to use engineered CAR T cells to specifically target the high-risk types of multiple myeloma.
Thanks to our episode sponsor, Takeda Oncology.
Dr. Wright will discuss 2 strategies for successful crowd funding and will feature a new project called JR Terrier Books
Get this months bonus package - Trinity Productivity Sheet
and make 3x as much money at Get Crowd Funded Now
Dauntless Software is taking their technology to the masses with a Indiegogo Crowdfunding Campaign.
Tracing the World's Food Supply with NFC Smart Phones
We will develop the software and services needed to simplify the automation of tracking a supply chain from point of origin to the moment of consumption
Traceability. This is a key word in the world-wide effort of ensuring the food we are eating is fresh, safe, and supplied by reputable farms. When we know where our food is coming from, we can keep the farmer and supply chain accountable to meet or exceed governmental standards against substandard crops and food borne diseases.
And what happens when a pathogen is found in our supply? With traceability, we will know which products to pull, which supply chain to check, and which farms to address.
Some traceability exists today but new regulations are taking effect that are pushing the supply chains toward a more granular understanding of where our food comes from and where it is going.
Join us Today at 5:30 Pacific Time for a Question and Answer Session with The Crowd
For more about Dauntless Software please visit https://www.indiegogo.com/projects/tracing-the-world-s-food-supply-with-nfc-smart-phones/x/1174327
Join Host Live Chats
- Star Nations Radio Network (22 chatters)
- Hoshaiah Israel (13 chatters)
- Clay Douglas (8 chatters)
- Success Freaks (7 chatters)
- Ice Cream Convos (5 chatters)
- Tracey and Friends (3 chatters)
- Jay King Network (2 chatters)
- Negdog Radio (1 chatters)
- New Twist Radio (1 chatters)
- The Road Less Traveled (1 chatters)
- Back Porch Writer (1 chatters)
- BodyMindSpirit Radio (1 chatters)
- Truth and Guidance Ministries (1 chatters)